Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection

Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection

A population pharmacokinetic analysis was performed to investigate the pharmacokinetics of moxifloxacin (400 mg) following a once-daily oral administration in 28 patients with respiratory tract infection disease. The maximum plasma concentration and the area under the plasma concentration–time curve...

Full description

Bibliographic Details
Main Authors: Fumitaka Ito, Yasushi Ohno, Sayaka Toyoshi, Daizo Kaito, Yanase Koumei, Junki Endo, Fumihiko Kamamiya, Hidenori Mori, Masahiro Mori, Megumi Morishita, Norihiko Funaguchi, Shinya Minatoguchi
Format: Article
Language:English
Published: SAGE Publishing 2016-02-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/1753465815620338

Internet

https://doi.org/10.1177/1753465815620338

Similar Items